Influence of patient's physiologic factors and immobilization choice with stereotactic body radiotherapy for upper lung tumors

被引:12
|
作者
Sio, Terence T. [1 ]
Jensen, Andrew R. [1 ]
Miller, Robert C. [1 ]
Santos, Luis E. Fong de los [1 ]
Hallemeier, Christopher L. [1 ]
Foster, Nathan R. [2 ]
Park, Sean S. [1 ]
Bauer, Heather J. [1 ]
Chang, Kenneth [1 ]
Garces, Yolanda I. [1 ]
Olivier, Kenneth R. [1 ]
机构
[1] Mayo Clin, Dept Radiat Oncol, Rochester, MN 55905 USA
[2] Mayo Clin, Div Biomed Stat & Informat, Rochester, MN 55905 USA
来源
关键词
body mass index; immobilization; pulmonary function test; stereotactic body radiation therapy; upper lung tumors; MEDICALLY INOPERABLE PATIENTS; RADIATION-THERAPY; PULMONARY-FUNCTION; CANCER; METASTASES; FRACTIONS; MOVEMENT; GUIDANCE; POSITION; SIZE;
D O I
10.1120/jacmp.v15i5.4931
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
The purpose of the present study was to compare the impact of pulmonary function, body habitus, and stereotactic body radiation therapy (SBRT) immobilization on setup and reproducibility for upper lung tumor. From 2008 through 2011, our institution's prospective SBRT database was searched for patients with upper lung tumors. Two SBRT immobilization strategies were used: full-length BodyFIX and thermoplastic S-frame. At simulation, free-breathing, four-dimensional computed tomography was performed. For each treatment, patients were set up to isocenter with in-room lasers and skin tattoos. Shifts from initial and subsequent couch positions with cone-beam computed tomography (CBCT) were analyzed. Accounting for setup uncertainties, institutional tolerance of CBCT-based shifts for treatment was 2, 2, and 4 mm in left-right, anterior-posterior, and cranial-caudal directions, respectively; shifts exceeding these limits required reimaging. Each patient's pretreatment pulmonary function test was recorded. A multistep, multivariate linear regression model was performed to elucidate intervariable dependency for three-dimensional calculated couch shift parameters. BodyFIX was applied to 76 tumors and S-frame to 17 tumors. Of these tumors, 41 were non-small cell lung cancer and 15 were metastatic from other sites. Lesions measured < 1 (15%), 1.1 to 2 (50%), 2.1 to 3 (25%), and > 3 (11%) cm. Errors from first shifts of first fractions were significantly less with S-frame than BodyFIX (p < 0.001). No difference in local control (LC) was found between S-frame and BodyFIX (p = 0.35); two-year LC rate was 94%. Multivariate modeling confirmed that the ratio of forced expiratory volume in the first second of expiration to forced vital capacity, body habitus, and the immobilization device significantly impacted couch shift errors. For upper lung tumors, initial setup was more consistent with S-frame than BodyFIX, resulting in fewer CBCT scans. Patients with obese habitus and poor lung function had more SBRT setup uncertainty; however, outcome and probability for LC remained excellent.
引用
收藏
页码:235 / 245
页数:11
相关论文
共 50 条
  • [41] Accelerated Hypofractionated Radiotherapy for Central Lung Tumors Unsuitable for Stereotactic Body Radiotherapy Or Concurrent CRT
    Zeng, K. L.
    Poon, I.
    Ung, Y.
    Zhang, L.
    Cheung, P.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S638 - S638
  • [42] Outcomes after stereotactic body radiotherapy for lung tumors, with emphasis on comparison of primary lung cancer and metastatic lung tumors
    Takaya Yamamoto
    Keiichi Jingu
    Yuko Shirata
    Masashi Koto
    Haruo Matsushita
    Toshiyuki Sugawara
    Masaki Kubozono
    Rei Umezawa
    Keiko Abe
    Noriyuki Kadoya
    Youjirou Ishikawa
    Maiko Kozumi
    Noriyoshi Takahashi
    Ken Takeda
    Yoshihiro Takai
    BMC Cancer, 14
  • [43] Positional uncertainties of cervical and upper thoracic spine in stereotactic body radiotherapy with thermoplastic mask immobilization
    Jeon, Seung Hyuck
    Kim, Jin Ho
    RADIATION ONCOLOGY JOURNAL, 2018, 36 (02): : 122 - 128
  • [44] The Feasibility and Efficacy of Stereotactic Body Radiotherapy for Centrally-located Lung Tumors
    Takahashi, Wataru
    Yamashita, Hideomi
    Omori, Mami
    Kitaguchi, Mayuka
    Shibata-Kobayashi, Shino
    Sakumi, Akira
    Nakagawa, Keiichi
    ANTICANCER RESEARCH, 2013, 33 (11) : 4959 - 4964
  • [45] Local Control & Toxicity Results of Stereotactic Body Radiotherapy in Central Lung Tumors
    Babayigit, Y.
    Bascik, O.
    Oz, S.
    Arslan, Y.
    Birgi, S. Duru
    Gumustepe, E.
    Kahya, Y.
    Akyurek, S.
    JOURNAL OF THORACIC ONCOLOGY, 2023, 18 (11) : S520 - S521
  • [46] The safety and effectiveness of stereotactic body radiotherapy for central versus ultracentral lung tumors
    Chang, Joe H.
    Poon, Ian
    Erler, Darby
    Zhang, Liying
    Cheung, Patrick
    RADIOTHERAPY AND ONCOLOGY, 2018, 129 (02) : 277 - 283
  • [47] Clinical characteristics and outcome of pneumothorax after stereotactic body radiotherapy for lung tumors
    Kaori Asai
    Katsumasa Nakamura
    Yoshiyuki Shioyama
    Tomonari Sasaki
    Yoshio Matsuo
    Saiji Ohga
    Tadamasa Yoshitake
    Kotaro Terashima
    Makoto Shinoto
    Keiji Matsumoto
    Hidenari Hirata
    Hiroshi Honda
    International Journal of Clinical Oncology, 2015, 20 : 1117 - 1121
  • [48] Outcomes and toxicity of stereotactic body radiotherapy for metastatic and recurrent central lung tumors
    Mou, B.
    Merrell, K. W.
    Owen, D. A.
    Nelson, K.
    Garces, Y. I.
    Olivier, K. R.
    RADIOTHERAPY AND ONCOLOGY, 2014, 111 : S99 - S99
  • [49] Biologically effective dose and overall survival in stereotactic body radiotherapy for lung tumors
    Osamu Tanaka
    Norihiko Funaguchi
    Sayaka Toyoshi
    Takuya Taniguchi
    Kousei Ono
    Chiyoko Makita
    Masayuki Matsuo
    memo - Magazine of European Medical Oncology, 2020, 13 : 353 - 356
  • [50] Stereotactic body radiotherapy for metastatic lung tumors with emphasis on the difference in oligometastatic state
    Yamamoto, T.
    Niibe, Y.
    Yamashita, H.
    Katsui, K.
    Nakagawa, K.
    Kanazawa, S.
    Kawamori, J.
    Koto, M.
    Terahara, A.
    Jingu, K.
    RADIOTHERAPY AND ONCOLOGY, 2015, 115 : S317 - S318